- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04453969
Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1a
October 25, 2022 updated by: Deborah O'Connor
The Canadian Paediatric Society recommends breastfeeding during COVID-19 infection.
Human milk is the best form of infant nutrition providing significant protection against many illnesses for term and preterm infants.
The impact of a pandemic on breastfeeding is unknown.
This study seeks to address this public health issue.
Breastmilk will be collected from mothers positive for COVID-19.
Samples will be analyzed for the COVID-19 virus specific nucleic acid and antibody in real-time and results will be immediately disseminated to relevant organizations to inform local, national and international guidelines surrounding breastfeeding to protect the health of infants.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
59
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 1X5
- Sinai Health System
-
Toronto, Ontario, Canada, M5S 1A8
- University of Toronto
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Community sample
Description
Inclusion Criteria:
- Current COVID-19 positive status or COVID-19 positive status during pregnancy
- Intent to breastfeed or currently breastfeeding
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Breastfeeding mothers positive for COVID-19
|
Exposure of interest for this observational study is current COVID-19 positive status or COVID-19 positive status during pregnancy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Presence of SARS-CoV-2 in breastmilk
Time Frame: 2-6 months
|
To describe the presence of SARS-CoV-2 nucleic acid in human milk samples collected from mothers positive for COVID-19
|
2-6 months
|
SARS-CoV-2 antibody in breastmilk
Time Frame: 2-6 months
|
To describe the presence of SARS-CoV-2 antibody in human milk samples collected from mothers positive for COVID-19
|
2-6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 24, 2020
Primary Completion (Anticipated)
April 27, 2023
Study Completion (Anticipated)
April 27, 2023
Study Registration Dates
First Submitted
June 29, 2020
First Submitted That Met QC Criteria
June 29, 2020
First Posted (Actual)
July 1, 2020
Study Record Updates
Last Update Posted (Actual)
October 26, 2022
Last Update Submitted That Met QC Criteria
October 25, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- 39373-a
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on SARS-CoV2
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Meshalkin Research Institute of Pathology of CirculationUnknown
-
University of Erlangen-Nürnberg Medical SchoolRecruiting
-
Universitair Ziekenhuis BrusselRecruiting
-
Centre Hospitalier Universitaire de BesanconActive, not recruiting
-
Instituto Nacional de Cancerologia de MexicoRoche Pharma AGActive, not recruiting
-
IRCCS San Raffaele RomaCompleted
-
Fondazione Epatocentro TicinoActive, not recruiting
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Centre Hospitalier Universitaire de BesanconCompleted
Clinical Trials on COVID-19
-
AstraZenecaCompleted
-
Hasanuddin UniversityChulalongkorn UniversityCompleted
-
Raphael SerreauAssistance Publique - Hôpitaux de Paris; University Hospital, Paris; François...CompletedCoronavirus InfectionFrance
-
Melike CengizCompleted
-
AstraZenecaCompleted
-
University of PennsylvaniaPublic Health Management CorporationCompleted
-
University of Texas at AustinUnknownFood InsecurityUnited States
-
University of PennsylvaniaPublic Health Management CorporationCompleted
-
Duke UniversityNorth Carolina Department of Health and Human ServicesCompleted
-
University of AberdeenNot yet recruitingCovid19 | Pulmonary Embolism